Rossari Biotech announced that the 15th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 19.44% to Rs 34.90 crore in the quarter ended June 2024 as against Rs 29.22 crore during the previous quarter ended June 2023. Sales rose 19.25% to Rs 489.65 crore in the quarter ended June 2024 as against Rs 410.61 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales489.65410.61 19 OPM %13.2514.05 - PBDT62.3653.57 16 PBT46.9939.46 19 NP34.9029.22 19 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 20 July 2024.Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 17.77% to Rs 34.13 crore in the quarter ended March 2024 as against Rs 28.98 crore during the previous quarter ended March 2023. Sales rose 16.30% to Rs 472.72 crore in the quarter ended March 2024 as against Rs 406.47 crore during the previous quarter ended March 2023.For the full year,net profit rose 21.84% to Rs 130.69 crore in the year ended March 2024 as against Rs 107.26 crore during the previous year ended March 2023. Sales rose 10.55% to Rs 1830.56 crore in the year ended March 2024 as against Rs 1655.88 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales472.72406.47 16 1830.561655.88 11 OPM %13.4513.43 -13.6413.47 - PBDT61.6453.25 16 238.01207.15 15 PBT45.5737.23 22 177.62144.22 23 NP34.1328.98 18 130.69107.26 22 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 29 April 2024.Powered by Capital Market - Live News